Comparing Afinitor Disperz vs Everolimus
| Afinitor Disperz (everolimus) | Everolimus |
|
|---|
| Afinitor Disperz (everolimus) | Everolimus |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Tuberous Sclerosis Complex, Subependymal Giant Cell Astrocytoma. Afinitor Disperz may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Neuroendocrine Tumors, Breast Cancer, Renal Angiomyolipoma, Tuberous Sclerosis Complex, Brain Tumor, Organ Transplant - Rejection Prophylaxis, Pancreatic Cancer, Renal Cell Carcinoma... View more |
Related suggestions Subependymal Giant Cell Astrocytoma
Tuberous Sclerosis Complex
Popular comparisons
|
|||||||||||||||
| More about Afinitor Disperz (everolimus) | More about Everolimus | ||||||||||||||||
| Ratings & Reviews | |||||||||||||||||
|
Be the first to share your experience with this drug. |
Everolimus has an average rating of 5.6 out of 10 from a total of 29 ratings on Drugs.com. 45% of reviewers reported a positive effect, while 38% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | |||||||||||||||||
|
View all Afinitor Disperz side effects |
View all Everolimus side effects |
||||||||||||||||
| Drug Class | |||||||||||||||||
| Generic Availability | |||||||||||||||||
|
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | |||||||||||||||||
View all Afinitor Disperz prices |
View all Everolimus prices |
||||||||||||||||
| Dosage Forms | |||||||||||||||||
|
|
||||||||||||||||
| Brand Names | |||||||||||||||||
| Other everolimus brands include: Afinitor, Torpenz, Zortress | Afinitor, Afinitor Disperz, Torpenz, Zortress | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | |||||||||||||||||
|
35 hours |
35 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | |||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | |||||||||||||||||
|
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | |||||||||||||||||
|
A total of 557 drugs are known to interact with Afinitor Disperz:
|
A total of 557 drugs are known to interact with Everolimus:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | |||||||||||||||||
|
|
||||||||||||||||
| Disease Interactions | |||||||||||||||||
| First Approval Date | |||||||||||||||||
|
N/A |
March 30, 2009 |
||||||||||||||||
| WADA Class View classifications | |||||||||||||||||
|
N/A |
N/A |
||||||||||||||||
| More Information | |||||||||||||||||
| Patient Resources | |||||||||||||||||
| Professional Resources | |||||||||||||||||
|
N/A |
|||||||||||||||||
| Related Treatment Guide | |||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Epidiolex
Epidiolex (cannabidiol) is an oral prescription liquid CBD medicine that may be used to treat ...
Afinitor
Afinitor prevents the growth of cancer cells and is used to treat advanced kidney cancer. Learn ...
Botox
Botox is used cosmetically to reduce facial lines and wrinkles and for medical purposes for ...
Zortress
Zortress (everolimus) is used to prevent organ rejection in adult kidney transplant recipients ...
Hyftor
Hyftor (sirolimus topical gel) is used for facial angiofibroma associated with tuberous sclerosis ...
Sirolimus topical
Sirolimus topical is used for angiofibroma, tuberous sclerosis complex
Cannabidiol
Cannabidiol information from Drugs.com, includes Cannabidiol side effects, interactions and indications.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.